compound pharmacy semaglutide Webster Semaglutide / Cyanocobalamin Injection |

Chiquette E, Toth PP, Ramirez G, Cobble M, Chilton R: Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

What metabolic markers are tracked

News release

It is a dual-action receptor agonist that works on both GLP-1 and gastric inhibitory polypeptide (GIP)

Before switching because of GI intolerance, we recommend ensuring that all reasonable mitigating actions have been implemented, including: 1 ) verifying that the patient is taking the prescribed dose of the current GLP-1 receptor agonist because dose reduction can often minimize or resolve GI symptoms

Gastrointestinal side effects include: Nausea (15-30% of patients depending on dose): Usually mild to moderate and decreasing over time Diarrhea (13-24%): May contribute to dehydration if persistent Vomiting (6-12%): More common at higher doses Constipation (5-17%): Can alternate with diarrhea in some patients Abdominal pain (6-10%): Typically mild and self-limiting Decreased appetite : An intended effect contributing to weight loss Hypoglycemia risk varies depending on concurrent medications